4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0001209191-19-057685
Director sold 42,000 shares at $67.41 ($2,831,388)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bolzon Bradley J PhD Director | 2019-11-19 | Sale | −13,745 | $67.41 | $926,605 | 0 | D |
| Bolzon Bradley J PhD Director | 2019-11-19 | Sale | −28,255 | $67.41 | $1,904,783 | 596,741 | I |
| Open-market sales · 42,000 sh · avg $67.41 · $2,831,388 | |||||||
Loading xslF345X03/doc4.xml…